Clinical Trial Update: QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression [Phase 3]

View source ↗

Summary

A Phase 3 study (QUIREDEX) evaluating lenalidomide plus dexamethasone versus observation in patients with smoldering multiple myeloma at high risk of progressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED